October 1, 2024 Investor Beware: Port Strike Puts Key Stocks And Sectors At Risk
September 30, 2024 Market Movers: Jobs Report and Key Earnings in Focus
September 19, 2024 Federal Reserve’s Aggressive Move Hints At Bold Economic Strategy
September 11, 2024 Top Stocks For Smart Investment Choices
Microsoft Stock Is Way Too Expensive Given These Risks Piling Up
Is A. O. Smith A Good Buy Ahead Of Its Q3 Results?
Tesla: I Would Rather ‘Sell The Rumor’
Microsoft: Back To Basics
October 3, 2024 Your Path to Profits: The Best Trading Platforms for New Traders
October 3, 2024 Mastering Trading Indicators: Your Essential Toolkit For Success
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
Medicenna Therapeutics (MDNA) stock forecast for 2026
Updated: October 9, 2024 (16:26)
Sector: HealthcareThe share price of Medicenna Therapeutics Corp. (MDNA) now
50/200 Day Moving Average: $ / $
This figure corresponds to the Average Price over the previous 50/200 days. For Medicenna Therapeutics stocks, the 50-day moving average is the support level today.
For Medicenna Therapeutics stocks, the 200-day moving average is the support level today.
Are you interested in Medicenna Therapeutics Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Medicenna Therapeutics stock price in 2026. How much will one Medicenna Therapeutics share be worth in 2026? Is it worth taking profit / loss on MDNA stock now or waiting? What are analysts' forecasts for Medicenna Therapeutics stock?
We forecast Medicenna Therapeutics stock performance using neural networks based on historical data on MDNA stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Medicenna Therapeutics Corp. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Medicenna Therapeutics analysts is $. Today 200 Day Moving Average is the support level ( $). 50 Day Moving Average is the support level ( $).
Historical and forecast chart of Medicenna Therapeutics Corp. stock
The chart below shows the historical price of Medicenna Therapeutics stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the MDNA stock price can be found in the table below.
Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company. It engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in Toronto, Canada.
Medicenna Therapeutics (MDNA) Forecast for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.23 | 0.20 | 0.24 | 19.09 % |
| Feb | 0.24 | 0.21 | 0.27 | 22.40 % |
| Mar | 0.25 | 0.23 | 0.27 | 14.84 % |
| Apr | 0.25 | 0.21 | 0.28 | 24.19 % |
| May | 0.23 | 0.20 | 0.26 | 22.71 % |
| Jun | 0.22 | 0.20 | 0.24 | 19.61 % |
| Jul | 0.22 | 0.20 | 0.25 | 19.86 % |
| Aug | 0.24 | 0.22 | 0.26 | 13.00 % |
| Sep | 0.25 | 0.21 | 0.28 | 24.11 % |
| Oct | 0.27 | 0.25 | 0.29 | 12.47 % |
| Nov | 0.27 | 0.23 | 0.29 | 20.09 % |
| Dec | 0.26 | 0.23 | 0.30 | 21.79 % |
Medicenna Therapeutics information and performance
N/A
Market capitalization of the Medicenna Therapeutics Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of MDNA shares in the company outstanding by the market price of one share.
EBITDA of Medicenna Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Medicenna Therapeutics price target for 2026 by month
Target values for the price of one Medicenna Therapeutics share for Jan 2026.
In Jan, the Negative dynamics for Medicenna Therapeutics Corp. shares will prevail with possible monthly volatility of 19.088% volatility is expected.
Pessimistic target level: 0.20
Optimistic target level: 0.24
Target values for the price of one Medicenna Therapeutics share for Feb 2026.
In Feb, the Positive dynamics for Medicenna Therapeutics Corp. shares will prevail with possible monthly volatility of 22.399% volatility is expected.
Pessimistic target level: 0.21
Optimistic target level: 0.27
Target values for the price of one Medicenna Therapeutics share for Mar 2026.
In Mar, the Positive dynamics for Medicenna Therapeutics Corp. shares will prevail with possible monthly volatility of 14.840% volatility is expected.
Pessimistic target level: 0.23
Optimistic target level: 0.27
Target values for the price of one Medicenna Therapeutics share for Apr 2026.
In Apr, the Negative dynamics for Medicenna Therapeutics Corp. shares will prevail with possible monthly volatility of 24.189% volatility is expected.
Pessimistic target level: 0.21
Optimistic target level: 0.28
Target values for the price of one Medicenna Therapeutics share for May 2026.
In May, the Negative dynamics for Medicenna Therapeutics Corp. shares will prevail with possible monthly volatility of 22.708% volatility is expected.
Pessimistic target level: 0.20
Optimistic target level: 0.26
Target values for the price of one Medicenna Therapeutics share for Jun 2026.
In Jun, the Negative dynamics for Medicenna Therapeutics Corp. shares will prevail with possible monthly volatility of 19.614% volatility is expected.
Pessimistic target level: 0.20
Optimistic target level: 0.24
Target values for the price of one Medicenna Therapeutics share for Jul 2026.
In Jul, the Negative dynamics for Medicenna Therapeutics Corp. shares will prevail with possible monthly volatility of 19.857% volatility is expected.
Pessimistic target level: 0.20
Optimistic target level: 0.25
Target values for the price of one Medicenna Therapeutics share for Aug 2026.
In Aug, the Positive dynamics for Medicenna Therapeutics Corp. shares will prevail with possible monthly volatility of 12.998% volatility is expected.
Pessimistic target level: 0.22
Optimistic target level: 0.26
Target values for the price of one Medicenna Therapeutics share for Sep 2026.
In Sep, the Positive dynamics for Medicenna Therapeutics Corp. shares will prevail with possible monthly volatility of 24.108% volatility is expected.
Pessimistic target level: 0.21
Optimistic target level: 0.28
Target values for the price of one Medicenna Therapeutics share for Oct 2026.
In Oct, the Positive dynamics for Medicenna Therapeutics Corp. shares will prevail with possible monthly volatility of 12.471% volatility is expected.
Pessimistic target level: 0.25
Optimistic target level: 0.29
Target values for the price of one Medicenna Therapeutics share for Nov 2026.
In Nov, the Positive dynamics for Medicenna Therapeutics Corp. shares will prevail with possible monthly volatility of 20.095% volatility is expected.
Pessimistic target level: 0.23
Optimistic target level: 0.29
Target values for the price of one Medicenna Therapeutics share for Dec 2026.
In Dec, the Negative dynamics for Medicenna Therapeutics Corp. shares will prevail with possible monthly volatility of 21.785% volatility is expected.
Pessimistic target level: 0.23
Optimistic target level: 0.30
